Lead identification of a potent benzopyranone selective estrogen receptor modulator

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

Starting from a phenol screening hit (6), three series of benzopyranone selective estrogen receptor modulators (SERMs) have been designed, synthesized, and analyzed for both estrogen receptor alpha binding affinity and in vitro activity in two cell assays. The lead compound identified, SP500263 (13), was more potent than raloxifene and tamoxifen in a cell-based assay measuring inhibition of interleukin-6 release.

Knowledge Graph

Similar Paper

Lead identification of a potent benzopyranone selective estrogen receptor modulator
Bioorganic & Medicinal Chemistry Letters 2004.0
2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs)
Bioorganic & Medicinal Chemistry Letters 2003.0
Identification and Structure−Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms
Journal of Medicinal Chemistry 2009.0
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity
Journal of Medicinal Chemistry 2018.0
Solid-Phase synthesis and investigation of benzofurans as selective estrogen receptor modulators
Bioorganic & Medicinal Chemistry Letters 2002.0
Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene:  A Novel, Highly Potent, Selective Estrogen Receptor Modulator
Journal of Medicinal Chemistry 1997.0
Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues:  Highly Potent Selective Estrogen Receptor Modulators
Journal of Medicinal Chemistry 1998.0
Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reaction
Bioorganic & Medicinal Chemistry Letters 2006.0
Benzothieno[3,2-b]indole derivatives as potent selective estrogen receptor modulators
Bioorganic & Medicinal Chemistry Letters 2005.0
Benzopyrans Are Selective Estrogen Receptor β Agonists with Novel Activity in Models of Benign Prostatic Hyperplasia
Journal of Medicinal Chemistry 2006.0